Market Place
Sourcing Support
Celularity Publishes Ph2 Data on PDA-002 for Diabetic Foot Ulcers
14 Oct 2025 //
GLOBENEWSWIRE
Celularity Retires $41.6 M in Senior Secured Debt
18 Aug 2025 //
GLOBENEWSWIRE
Celularity & Fountain Life Partner for Stem Therapies in Florida
09 Jul 2025 //
GLOBENEWSWIRE
Celularity Applauds Florida Stem Cell Access Law
01 Jul 2025 //
GLOBENEWSWIRE
Celularity Announces Publication in Frontiers in Immunology
07 Apr 2025 //
GLOBENEWSWIRE
Celularity Gets FDA Recommendation For Natalin & Acelagraft
25 Feb 2025 //
GLOBENEWSWIRE
Celularity Enters Strategic Collaboration With Cell Therapy Company
24 Feb 2025 //
GLOBENEWSWIRE
Celularity Inc. Gets Nasdaq Notice; Plans To Appeal.
18 Oct 2024 //
GLOBENEWSWIRE
Celularity Expands Biomaterial Product Portfolio With Rebound
16 Oct 2024 //
GLOBENEWSWIRE
Celularity Inc. Gets Nasdaq Notice For Late Form 10-Q Filing
23 Aug 2024 //
GLOBENEWSWIRE
Celularity Nasdaq Late Filing: Form 10-Q Notice Received By Company
24 May 2024 //
GLOBENEWSWIRE
Celularity Placental T Cell Data Shows CAR-T Therapy Benefits
14 May 2024 //
GLOBENEWSWIRE
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
19 Apr 2024 //
GLOBENEWSWIRE
Celularity Abstract On Placental Biomaterials For Tendons At ORS 2024
18 Apr 2024 //
GLOBENEWSWIRE
Celularity to Present Data Showing Senescent Cell Elimination
08 Apr 2024 //
GLOBENEWSWIRE
Celularity Submits Request to U.S. FDA for ODD for PDA-002 Asset FMD
20 Mar 2024 //
GLOBENEWSWIRE
Celularity CEO to Present on Cell Therapy™s Potential
14 Mar 2024 //
GLOBENEWSWIRE
Celularity to Present Data Showing Cancer Tumor Reduction by Cell Therapy
07 Mar 2024 //
GLOBENEWSWIRE
Celularity Announces 1-for-10 Reverse Stock Split
23 Feb 2024 //
GLOBENEWSWIRE
Celularity and Genting Leaders Comments on Closing $21M Financing Transactions
25 Jan 2024 //
GLOBENEWSWIRE
Celularity Confirms Commercialization Agreement with BioCellgraft
04 Jan 2024 //
GLOBENEWSWIRE
Celularity Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
24 Nov 2023 //
GLOBENEWSWIRE
Celularity Appoints Geoffrey Shiu Fei Ling to its Board of Directors
07 Sep 2023 //
GLOBENEWSWIRE
Celularity Inks Research Collaboration with Regeneron
01 Sep 2023 //
CONTRACT PHARMA
Celularity and Verséa Announce Exclusive U.S. Commercialization Agreement
27 Jul 2023 //
GLOBENEWSWIRE
Celularity Inc. Announces $3 Million Registered Direct Offering
27 Jul 2023 //
GLOBENEWSWIRE
Celularity Announces Presentation at Upcoming 7th International Conference
29 Jun 2023 //
GLOBENEWSWIRE
Celularity Tissue Factor Gene Knockout of Allogeneic Stromal Cells Lowers Thrombotic Effects
01 Jun 2023 //
GLOBENEWSWIRE
Celularity Announces Phase 1 Data Showing That MLASC Therapy in Patients
19 May 2023 //
GLOBENEWSWIRE
Celularity Announces Acceptance of Presentation at 26th Annual Meeting
01 May 2023 //
GLOBENEWSWIRE
Celularity Announces Clinical Data onHuman Placental-Derived Unmodified Cynk-001
27 Apr 2023 //
GLOBENEWSWIRE
Celularity Inc. Announces $6 Million Registered Direct Offering
05 Apr 2023 //
GLOBENEWSWIRE
Celularity Announces Acceptance of Poster Presentation at 2023 Annual Meeting
04 Apr 2023 //
GLOBENEWSWIRE
Celularity & CH Group Announce Product Distribution Agreement with Tamer Group
11 Jan 2023 //
PR NEWSWIRE
Celularitya Placental-Derived Allogeneic Cell Therapy Clinically Meaningful
06 Jan 2023 //
GLOBENEWSWIRE
